Saturday 17 October 2026
Export PAVM’s income statement to Excel — free account
PAVmed Inc.
PAVM Healthcare Medical Devices
PAVmed Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71,000.00, down 97.6% from fiscal 2024. In the quarter to June 2026, revenue grew 450.0%, EPS grew 96.1% and free cash flow fell 125.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
2.41
0.02
−0.82%
Follow PAVM
PAVmed Inc. (PAVM) P/E ratio
PAVmed Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 2.1× (October 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.9× | 297.60% |
| FY2024 | 0.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.9× | (8.91%) |
| Sep 2025 | 1.0× | 1,092.84% |
| 15 more quarters | Free account |
Against its own ten years
Low 0.0×
High 2.1×
Ten-year median
0.0×
Current reading's percentile
86
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| LFWD Lifeward Ltd. compare | n/m |
| MODD Modular Medical, Inc. compare | n/m |
| PAVM PAVmed Inc. | n/m |
| NSPR InspireMD, Inc. compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| ARAY Accuray Incorporated compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| PMI Flag Ship Acquisition Corp compare | 0.5× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)